control group:Basic treatment of modern medicine
Sponsors
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Huashan Hospital Affiliated to Fudan University
Conditions
Coronavirus diseaseNovel Coronavirus Pneumonia (COVID-19)
Early Phase 1
Effect evaluation and prognosis of Chinese medicine based on Novel Coronavirus Pneumonia (COVID-19)
RecruitingChiCTR2000029747
Start: 2020-02-11Updated: 2020-02-17
Randomized controlled clinical study on the efficacy and safety of COVID-19 No.2 formula (Yiqing oral liquid) in the treatment of variant strains of Omicron virus infection (asymptomatic and mild) in Huashan Hospital
Active, not recruitingChiCTR2200058800
Start: 2022-04-18Updated: 2024-01-22